© Copyright 2002 Frost & Sullivan. All Rights Reserved. U.S. Botulinum Toxin Emerging Markets Under-Treated Disease States Create Strong Market Opportunity

© Copyright 2002 Frost & Sullivan. All Rights Reserved.

U.S. Botulinum Toxin Emerging Markets

Under-Treated Disease States Create Strong Market Opportunity for Off-Label Use of Botulinum Toxin

“The clinically proven efficacy of botulinum toxin in under-treated disease states such as pain management, spasticity, and primary and secondary focal dystonia

is expected to significantly increase its off-label use in these categories.”

Pharmaceutical Biotech Analyst Team

Frost & Sullivan


Frost & Sullivan provides:

• Detailed insights into recent developments and trends

• Drivers, restraints, challenges, and strategic recommendations

• Analyst insights on ‘hot topics’ and emerging applications in the market

• Market sizing and competitive analysis

• Market forecasts and opportunity analysis

• Quarterly assessments

• End user analysis within each report

Key Features


• Coverage: The United States

• Proven methodology encompassing extensive primary and secondary data and research

• Focused information and strategies that cover business and technology issues

• Credible data and analysis highlighting industry dynamics

• Winning strategies to help you create precise business plans

What We Offer


Current Market Participants• Find out how you compare to the competition• Assess current and future drivers and restraints• Determine and exploit new market share opportunities

New Entrants • Analyze challenges associated with the industry• Calculate time scales for strategy implementation• Position yourself to capitalize on the market’s unmet needs

Investment Community• Analyze long-term strategies of companies• Determine which participants will outperform the competition• Assess attractiveness of investing in the market

Who Will Benefit?


Allergan, Inc.Elan Pharmaceuticals, Inc.Ipsen, Inc.INAMED Corp.

Key Market Participants


• Call toll free 877 GO FROST

(877.463.7876)

• Fax toll free 888.690.3329

• E-mail [email protected]

• Visit www.frost.com

For More Information

Documents

© Copyright 2002 Frost & Sullivan. All Rights Reserved. U.S. Botulinum Toxin Emerging Markets Under-Treated Disease States Create Strong Market Opportunity